Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells

被引:68
|
作者
Wang, Qinwen [1 ]
Chen, Zhengtang [1 ]
Diao, Xinwei [2 ]
Huang, Shengbing [3 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Oncol Res Inst, Chongqing 400037, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Dept Pathol, Chongqing 400037, Peoples R China
[3] Mayo Clin, Mayo Canc Ctr, Rochester, MN 55905 USA
基金
中国国家自然科学基金;
关键词
Survivin; YM155; Autophagy; Apoptosis; TRAIL-MEDIATED APOPTOSIS; MONITORING AUTOPHAGY; BECLIN; PROTEINS; EXPRESSION; INHIBITOR; YEAST;
D O I
10.1016/j.canlet.2010.12.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we demonstrated that YM155, a novel survivin suppressant, induced both apoptosis, and autophagy that was shown by conversion of cytosolic-associated protein light chain 3 (LC3I) into autophagosome-associated form (LC3II) and a punctate fluorescence pattern of an ectopic GFP-LC3 protein. The lysosomal inhibitor chloroquine further accumulated YM155-induced LC3II, indicating an increase of autophagic flux. Ectopic expression of survivin significantly attenuated YM155-induced apoptosis and autophagy, whereas suivivin siRNA induced autophagy. Furthermore, inhibition of either early or late events of autophagy attenuated YM155-induced apoptosis, demonstrating that induction of autophagy proceeds apoptosis. In conclusion, suppression of survivin by YM155 induces autophagy-dependent apoptosis, and YM155-induced autophagy plays a pro-apoptotic role thereby unveiling a novel mechanism of YM155 in prostate cancer cells. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 50 条
  • [41] Interleukin Enhancer-binding Factor 3/NF110 Is a Target of YM155, a Suppressant of Survivin
    Nakamura, Naoto
    Yamauchi, Tomohiro
    Hiramoto, Masashi
    Yuri, Masatoshi
    Naito, Masanori
    Takeuchi, Masahiro
    Yamanaka, Kentaro
    Kita, Aya
    Nakahara, Takahito
    Kinoyama, Isao
    Matsuhisa, Akira
    Kaneko, Naoki
    Koutoku, Hiroshi
    Sasamata, Masao
    Yokota, Hiroyuki
    Kawabata, Shigeki
    Furuichi, Kiyoshi
    MOLECULAR & CELLULAR PROTEOMICS, 2012, 11 (07)
  • [42] Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells
    Yamazaki, Hiroki
    Takagi, Satoshi
    Hosoya, Kenji
    Okumura, Masahiro
    VETERINARY JOURNAL, 2015, 205 (03): : 375 - 380
  • [43] Antitumor effects of YM155, a novel survivin suppressant, against human aggressive non-Hodgkin lymphoma
    Kita, Aya
    Nakahara, Takahito
    Yamanaka, Kentaro
    Nakano, Kenji
    Nakata, Mari
    Mori, Masamichi
    Kaneko, Naoki
    Koutoku, Hiroshi
    Izumisawa, Nobuyuki
    Sasamata, Masao
    LEUKEMIA RESEARCH, 2011, 35 (06) : 787 - 792
  • [44] YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells
    Feng, Weiying
    Yoshida, Akira
    Ueda, Takanori
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 435 (01) : 52 - 57
  • [45] Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model
    Murakami, Yoshihiro
    Matsuya, Takahiro
    Kita, Aya
    Yamanaka, Kentaro
    Noda, Akihiro
    Mitsuoka, Keisuke
    Nakahara, Takahito
    Miyoshi, Sosuke
    Nishimura, Shintaro
    NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (02) : 221 - 226
  • [46] CHARACTERIZATION OF THE CARRIER-MEDIATED HEPATIC UPTAKE OF YM155, A NOVEL SURVIVIN SUPPRESSANT, INTO CRYOPRESERVED HUMAN HEPATOCYTES
    Iwai, Megumi
    Minematsu, Tsuyoshi
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM REVIEWS, 2007, 39 : 67 - 67
  • [47] YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin
    Nitta, Takashi
    Koike, Hidekazu
    Miyao, Takeshi
    Miyazawa, Yoshiyuki
    Kato, Haruo
    Furuya, Yosuke
    Sekine, Yoshitaka
    Suzuki, Kazuhiro
    ANTICANCER RESEARCH, 2017, 37 (01) : 75 - 80
  • [48] YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts
    Nakahara, Takahito
    Takeuchi, Masahiro
    Kinoyama, Isao
    Minematsu, Tsuyoshi
    Shirasuna, Kenna
    Matsuhisa, Akira
    Kita, Aya
    Tominaga, Fumiko
    Yamanaka, Kentaro
    Kudoh, Masafumi
    Sasamata, Masao
    CANCER RESEARCH, 2007, 67 (17) : 8014 - 8021
  • [49] Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
    Tao, Yan-Fang
    Lu, Jun
    Du, Xiao-Juan
    Sun, Li-Chao
    Zhao, Xuan
    Peng, Liang
    Cao, Lan
    Xiao, Pei-Fang
    Pang, Li
    Wu, Dong
    Wang, Na
    Feng, Xing
    Li, Yan-Hong
    Ni, Jian
    Wang, Jian
    Pan, Jian
    BMC CANCER, 2012, 12
  • [50] YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression
    Mir, Roser
    Stanzani, Elisabetta
    Martinez-Soler, Fina
    Villanueva, Alberto
    Vidal, August
    Condom, Enric
    Ponce, Jordi
    Gil, Joan
    Tortosa, Avelina
    Gimenez-Bonafe, Pepita
    GYNECOLOGIC ONCOLOGY, 2014, 132 (01) : 211 - 220